NCT00215904View on ClinicalTrials.gov

D-serine Adjuvant Treatment for Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Parkinson's Disease
Interventions
DRUG

D-serine (~2g/day)

Two 6 weeks treatment arms. One arm: adjuvant treatment with D-serine (\~2g/day). Second arm : adjuvant treatment with placebo (\~2g/day).

Trial Locations (1)

91351

Ezrath Nashim - Herzog Memorial Hospital, Jerusalem

All Listed Sponsors
lead

Herzog Hospital

OTHER

NCT00215904 - D-serine Adjuvant Treatment for Parkinson's Disease | Biotech Hunter | Biotech Hunter